Skip to main content

Table 5 Descriptive analysis of participant self-reported outcomes for participants who had data at baseline and 3–5 days, by study arm

From: Managing uncertain recovery for patients nearing the end of life in hospital: a mixed-methods feasibility cluster randomised controlled trial of the AMBER care bundle

Primary outcome measures

Baseline, mean (SD)

3–5 days, mean (SD)

10–15 days, mean (SD)

IPOS subscale 5

Control, N = 12

13.3 (4.8)

13.3 (3.9)

10.3 (1.2) 1

Intervention, N = 12

13.3 (5.1)

14.6 (4.1)

13.9 (5.3) 2

howRwe 6

Control, N = 8

13.1 (2.5)

13.9 (2.5)

14 (2.0) 3

Intervention, N = 2

11.5 (2.1)

12.0 (0)

11 (N/A)4

  1. 1N = 3
  2. 2N = 7
  3. 3N = 3
  4. 4N = 1
  5. 5 A higher score is worse for patients. For the subscale, seven items are scored 0–4. Possible scores range from 0 to 28
  6. 6 A higher score is better. Four items are scored 1–4. Possible scores range from 4 to 16
  7. SD standard deviation